Highlights Cardax, Inc.

Equities

CDXI

US14141D2018

Delayed OTC Markets Other stock markets 09:38:51 2023-12-27 EST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2021	Cardax, Inc. announced a financing transaction	CI
2021	Cardax, Inc. Announces Restructuring of Board of Directors	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Cardax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-14	CI
Cardax, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-13	CI
Cardax, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-14	CI
Cardax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-15	CI
Cardax, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-30	CI
Cardax, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-14	CI
Cardax Announces Interim Results from CHASE Clinical Trial	19-09-23	CI
Cardax, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-14	CI
Cardax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-15	CI
Cardax, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-28	CI
Cardax, Inc. Announces CHASE Clinical Trial Initiated- Rx Development Plans for CDX-101 and CDX-301	19-03-28	CI
Cardax, Inc. Launches Human Clinical Trial Targeting Cardiovascular Inflammatory Health	18-10-02	CI
Cardax, Inc. Signs a Purchase Agreement with Health Elite Club Limited for Distribution of ZanthoSyn in China, Hong Kong, Macau, and Taiwan	18-02-17	CI
ZanthoSyn® from Cardax Now Available at 3,000+ GNC Corporate Stores in the U.S	17-12-07	CI
Cardax, Inc. and General Nutrition Corporation Sign Mutual Exclusivity Agreement for Zanthosyn	17-10-20	CI
Cardax Welcomes Cardiovascular Research Clinical Study	17-09-19	CI
Cardax, Inc. Receives Purchase Order from General Nutrition Corporation	17-08-10	CI
Cardax Astaxanthin Compound Chosen for Important NIA Anti-Aging Research Program	17-06-18	CI
Cardax Astaxanthin Compound CDX-085 Stimulates Anti-Aging Gene in Mice	17-03-28	CI
Cardax, Inc. Launches of ZanthoSyn to Help Consumers Safely Address Their Inflammatory Health	16-11-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cardax, Inc.

Equities

CDXI

US14141D2018

Highlights

Filters